+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 60Years
All Genders
ID04271878

Study of Controlled Carbon Dioxide Levels to Reduce Symptoms and Heart Rate in Adults with Postural Tachycardia Syndrome

Led by University of Calgary · Updated on 2026-05-07

26

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Postural orthostatic tachycardia syndrome POTS involves various causes, including issues with the sympathetic nervous system. This research aims to see if higher levels of carbon dioxide CO2 can lower heart rate and reduce POTS symptoms when standing. The study also seeks to find the ideal CO2 concentration for the best response. Participants will use the RespirAct system, a device that controls the gases they breathe to adjust blood CO2 levels. The study includes several tilt table tests HUTT with different breathing conditions, including normal breathing, mild and high hypercapnia increased CO2, and fast, deep breathing. All participants receive the same interventions using a face mask connected to the RespirAct system. During the study, participants will be monitored for heart rate changes, cerebral blood flow, and symptom intensity during each tilt test. Data on gas concentrations, breathing rate, and volume will be recorded breath-by-breath. The study also includes safety monitoring for adverse events and keeps participant information confidential. The main measure is heart rate variation during tilt tests, with follow-up lasting through all interventions.

CONDITIONS

Brief Title

Hypercapnia and Orthostatic Tolerance in Postural Orthostatic Tachycardia Syndrome

Research Team

S

Shaun Ranada, BSc

R

Rasha Hamza, RN

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here